Heikki Joensuu

Person

Curriculum Vitae

Latest publications

  1. Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy

    Lepikhova, T., Karhemo, P-R., Louhimo, R., Yadav, B., Murumägi, A., Kulesskiy, E., Kivento, M., Sihto, H., Grenman, R., Syrjänen, S. M., Kallioniemi, O., Aittokallio, T., Wennerberg, K., Joensuu, H. & Monni, O., Sep 2018, In : Molecular Cancer Therapeutics. 17, 9, p. 2060-2071 12 p.

    Research output: Contribution to journalArticleScientificpeer-review

  2. Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer The SOLD Randomized Clinical Trial

    Joensuu, H. , Fraser, J. , Wildiers, H. , Huovinen, R. , Auvinen, P. , Utriainen, M. , Nyandoto, P. , Villman, K. K. , Halonen, P. , Granstam-Björneklett, H. , Lundgren, L. , Sailas, L. , Turpeenniemi-Hujanen, T. , Tanner, M. , Yachnin, J. , Ritchie, D. , Johansson, O. , Huttunen, T. , Neven, P. , Canney, P. & 3 others Harvey, V. J., Kellokumpu-Lehtinen, P-L. & Lindman, H., Sep 2018, In : JAMA Oncology. 4, 9, p. 1199-1206 8 p.

    Research output: Contribution to journalArticleScientificpeer-review

  3. p95HER2 Methionine 611 Carboxy-Terminal Fragment Is Predictive of Trastuzumab Adjuvant Treatment Benefit in the FinHer Trial

    Sperinde, J., Huang, W., Vehtari, A., Chenna, A., Kellokumpu-Lehtinen, P-L., Winslow, J., Bono, P., Lie, Y. S., Petropoulos, C. J., Weidler, J. & Joensuu, H., 1 Jul 2018, In : Clinical Cancer Research. 24, 13, p. 3046-3052 7 p.

    Research output: Contribution to journalArticleScientificpeer-review

View all (331) »

Latest activities

  1. HUS Syöpätautien klinikka 75V yleisötilaisuus

    Joensuu, H. (Speaker: Keynote)
    10 Nov 2011

    Activity: Participating in or organising an eventPublic Talks

  2. 13th Annual AGITG Scientific Meeting

    Joensuu, H. (Speaker: Keynote)
    26 Aug 2011

    Activity: Participating in or organising an eventOrganisation and participation in conferences, workshops, courses, seminars

  3. 47th Annual Meeting of the American Society of Clinical Oncology.

    Joensuu, H. (Speaker: Keynote)
    6 Jun 2011

    Activity: Participating in or organising an eventOrganisation and participation in conferences, workshops, courses, seminars

View all (34) »

Latest prizes

  1. Matti Äyräpään palkinto

    Heikki Joensuu (Recipient), 2012

    Prize: Prizes and awards

  2. Fellow of the European Academy of Cancer Sciences

    Heikki Joensuu (Recipient), 2010

    Prize: Prizes and awards

View all (5) »

ID: 19445